Jaktinib

jaktinib · Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Jaktinib, covering 2023-01-17 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS) [Phase 3]